| 期 |
标题 |
文件 |
| 卷 17, 编号 3 (2025) |
Adiponectin as an important link in the pathogenesis of protein-energy malnutrition in patients receiving treatment with programmed hemodialysis: yes or no? |
|
|
Yakovenko A., Lavrishcheva Y.
|
| 卷 17, 编号 1 (2025) |
Analysis of demographic, clinical and laboratory parameters in COVID-19 patients with acute kidney injury |
|
|
Abdurakhimov A.
|
| 卷 15, 编号 4 (2023) |
Analysis of functional results of surgical treatment of kidney cancer |
|
|
Popov S., Guseynov R., Yesayan A., Sivak K., Perepelitsa V., Sadovnikova A., Grushevsky R., Lelyavina T.
|
| 卷 17, 编号 2 (2025) |
Anemia in chronic kidney disease. Prevalence and relationship with renal function parameters |
|
|
Murkamilov I., Aitbaev K., Fomin V., Raimzhanov Z., Khakimov S., Duysheeva G., Abdurakhmanov I., Solizhonov Z., Boymurodov Y., Yusupova T., Yusupova Z., Yusupov F., Abdibaliev I., Gasanov K., Khabibullaev K., Ymankulov D.
|
| 卷 15, 编号 4 (2023) |
Arterial hypertension in kidney transplantation – modern therapy strategy |
|
|
Nosov V., Koroleva L., Solovyanova E.
|
| 卷 17, 编号 3 (2025) |
ISPD Position Statement on Assisted Peritoneal Dialysis |
|
|
Berdinsky V., Ilyin A., Kargalskaya I., Kotenko O.
|
| 卷 16, 编号 4 (2024) |
Biological significance of differentially expressed genes of hypoxic-ischemic acute kidney injury (part 2) |
|
|
Popov S., Guseinov R., Yesayan A., Isakova-Sivak I., Sivak K., Skryabin O., Gorbacheva I., Matveeva D., Grushevsky R., Kovalevskaya A., Beshtoev A., Malyshev E., Lelyavina T.
|
| 卷 16, 编号 2 (2024) |
Biological significance of differentially expressed genes in hypoxic-ischemic acute kidney injury |
|
|
Popov S., Guseinov R., Yesayan A., Skryabin O., Vasin A., Kovalevskaya A., Perepelitsa V., Beshtoev A., Lelyavina T.
|
| 卷 17, 编号 2 (2025) |
Biomarkers of fibroplastic changes in the kidney in unilateral ureteral obstruction |
|
|
Shormanov I., Zhigalov S., Solovyev A., Bazhina O., Shormanova N.
|
| 卷 15, 编号 2 (2023) |
Castleman's disease associated with amyloidosis. Literature review and clinical observation |
|
|
Frolova N., Varyasin V., Volgina G., Sysoeva I., Mudarisov R., Usatyuk S., Dyakova E., Stolyarevich E.
|
| 卷 17, 编号 2 (2025) |
Are your kidneys ok? Detect early to protect kidney health |
|
|
Vassalotti J., Francis A., Dos Santos Jr A., Correa-Rotter R., Abdellatif D., Hsiao L., Roumeliotis S., Haris A., Kumaraswami L., Lui S., Balducci A., Liakopoulos V.
|
| 卷 16, 编号 3 (2024) |
Effect of intensive therapy of acute renal failure on stroke output depending on age |
|
|
Mukhitdinova K., Mamatkulov B.
|
| 卷 16, 编号 3 (2024) |
The effect of optimization of diuretic therapy on kidney function during circulartory decompensation |
|
|
Abdullaev O., Vereshchak D., Dragunov D., Sokolova A., Rylova A., Arutyunov G.
|
| 卷 16, 编号 2 (2024) |
External validity of the international method for predicting clinical outcome of immunoglobulin A-nephropathy in the Belarusian cohort of patients |
|
|
Komissarov K., Krasko O., Pilotovich V., Dmitrieva M., Letkovskaya T., Prilutsky S.
|
| 卷 16, 编号 2 (2024) |
Mind the gap in kidney care: translating what we know into what we do |
|
|
Luyckx V., Tuttle K., Abdellatif D., Correa-Rotter R., Fung W., Haris A., Hsiao L., Khalife M., Kumaraswami L., Loud F., Raghavan V., Roumeliotis S., Sierra M., Ulasi I., Wang B., Lui S., Liakopoulos V., Balducci A.
|
| 卷 16, 编号 3 (2024) |
Age- and gender-related features of chronic kidney disease in residents of the Circopolar North |
|
|
Zhmurov V., Vanuito E., Zhmurov D., Oskolkov S., Petrova Y., Zhmurova E., Ermakova A., Ermakova P.
|
| 卷 17, 编号 3 (2025) |
Volumetric assessment of polycystic kidneys using computerized planimetry: analysis of accuracy and clinical significance |
|
|
Trushkin R., Medvedev P., Fettser D.
|
| 卷 16, 编号 1 (2024) |
Secondary hyperparathyroidism in patients with chronic kidney disease in Tyumen region: five-year follow-up data |
|
|
Avdeeva V., Syachina S., Eirich V., Zhmurov D., Zhmurov V.
|
| 卷 15, 编号 3 (2023) |
Choice of surgical tactics for calculous anuria in infants |
|
|
Nasirov A., Khotamov K., Baiakhmedov F., Khoshimov T.
|
| 卷 17, 编号 2 (2025) |
Gender features of hemostasis regulation in hematuria associated with nephrolithiasis |
|
|
Barinov E., Akhundova S., Giller D.
|
| 卷 17, 编号 1 (2025) |
Gender differences in kidney function in COVID-19 |
|
|
Perepelitsa S.
|
| 卷 15, 编号 4 (2023) |
Genetic markers of thrombogenic risk in patients on program hemodialysis |
|
|
Voskresenskaya N., Orlova G., Romazina N.
|
| 卷 16, 编号 3 (2024) |
Glomerulonephritis in patients with previous coronavirus infection. Risks and consequences |
|
|
Polovikov I., Zakharova V., Sizova Z., Lapidus N., Shoikhet D., Lenkova N.
|
| 卷 15, 编号 3 (2023) |
Double-blind, randomized, phase I trial comparing the pharmacokinetics and safety of agalsidase beta bioanaloguer (Fabagal®) and the original drug (Fabrazim®) in healthy volunteers |
|
|
Moiseev S., Shchulkin A., Abalenikhina Y., Mylnikov P., Yakusheva E., Khmelevsky M., Macyak M.
|
| 卷 15, 编号 4 (2023) |
Diagnostic value of echocardiography parameters for assessing intravascular status in nephrotic syndrome in children |
|
|
Mamatkulov B., Mamatkulov I.
|
| 卷 15, 编号 2 (2023) |
Remote monitoring of renal transplant recipients |
|
|
Ivanova E., Kotenko O., Kargalskaya I., Vinogradov V., Berdinsky V., Artyukhina L., Frolova N.
|
| 卷 15, 编号 3 (2023) |
The significance of TNF-α in the pathogenesis of protein-energy malnutrition in patients on program hemodialysis |
|
|
Yakovenko A., Lavrishcheva Y., Rumyantsev A., Belskikh A.
|
| 卷 16, 编号 3 (2024) |
Difficulties in diagnosis and treatment of idiopathic cryoglobulinemic glomerulonephritis |
|
|
Grigoryeva E., Voloshinova E., Balkizova D., Myasnikova A.
|
| 卷 15, 编号 2 (2023) |
Intraoperative ultrasound navigation in minimally invasive organ-preserving treatment of renal cell carcinoma of a transplanted kidney |
|
|
Trushkin R., Isaev T., Medvedev P., Sokolov S., Morozov N., Parshin V., Son A., Klementyeva T.
|
| 卷 15, 编号 4 (2023) |
The use of modern MIS with elements of artificial intelligence in nephrology and precision renal replacement therapy |
|
|
Bolshakov S., Shutov E., Dolidze D., Sorokoletov S.
|
| 卷 16, 编号 4 (2024) |
History of the anatomy of the urinary system |
|
|
Subotialov M., Subotialova A.
|
| 卷 16, 编号 1 (2024) |
Quality of life in diabetic patients with chronic kidney disease |
|
|
Butranova O., Zyryanov S.
|
| 卷 15, 编号 3 (2023) |
Intestinal fatty acid binding protein as biomarker of enterocyte injury in patients with renal failure |
|
|
Pyatchenkov M., Sherbakov E., Trandina A., Belskykh A.
|
| 卷 15, 编号 1 (2023) |
Clinical and functional characteristics of mineral and bone disorders in chronic kidney disease |
|
|
Murkamilov I., Fomin V., Murkamilova Z., Sabirova A., Sabirov I., Yusupov F., Maanaev T., Zakirov O., Gasanov K.
|
| 卷 17, 编号 3 (2025) |
Clinical and epidemiological data on catheter-associated bloodstream infections among patients undergoing hemodialysis treatment |
|
|
Mirazimova I., Karunnaya A., Yesayan A.
|
| 卷 15, 编号 1 (2023) |
Clinical evaluation of uropathogen selection in vivo |
|
|
Berdichevsky V., Berdichevsky B., Sapozhenkova E., Pavlova I., Gonyaev A., Boldyrev A., Korabelnikov M., Petrov D., Spirina D.
|
| 卷 17, 编号 1 (2025) |
Clinical cases of acute kidney injury under conditions of exposure to short-term abnormal heat waves |
|
|
Murkamilov I., Aitbaev K., Fomin V., Yusupov F., Yusupova T., Yusupova Z., Duysheeva G., Khakimov S., Solizhonov Z., Ymankulov D.
|
| 卷 16, 编号 3 (2024) |
Clinical case of severe recurrent campylobacteriosis in a patient - renal transplant recipient |
|
|
Iskhakov R., Frolova N., Arbolishvili G., Kuzmenko M., Artyukhina L., Andreev S., Kobzar M., Frolov A.
|
| 卷 16, 编号 3 (2024) |
Clinical case of successful treatment of granulomatosis with polyangiitis |
|
|
Frolova N., Mutovina Z., Kobzar M., Arbolishvili G., Pavlov D., Shmeleva D., Manerov F., Lysenko M.
|
| 卷 17, 编号 3 (2025) |
Short-chain fatty acids as predictors of renal function decline in patients with sarcopenia and CHF |
|
|
Sokolova A., Dragunov D., Klimova A., Stafeeva E., Stafeev A., Golubev Y., Shmigol T., Negrebetsky V., Arutyunov G.
|
| 卷 16, 编号 4 (2024) |
Hemostasis system markers (coagulation factors) and left ventricle geometry in proteinuric variants of chronic kidney disease |
|
|
Murkamilov I., Aitbaev K., Fomin V., Yusupov F., Yusupova T., Yusupova Z., Duysheeva G., Khakimov S., Solizhonov Z., Ymankulov D.
|
| 卷 15, 编号 1 (2023) |
Methods of nutrition therapy of patients with chronic kidney disease |
|
|
Mikhailova N.
|
| 卷 15, 编号 2 (2023) |
Mechanisms of albumin loss against the background of the use of modern methods of renal replacement therapy |
|
|
Litvinov A., Gasanov M., Kuznetsova Y., Gergia S., Shevchenko S.
|
| 卷 17, 编号 3 (2025) |
Mechanisms of regulation of compensatory platelet response in nephrolithiasis-associated hematuria in women with the follicular phase of the cycle |
|
|
Barinov E., Akhundova S.
|
| 卷 15, 编号 4 (2023) |
Myostatin is an important link in the pathogenesis of protein-energy deficiency in patients on program hemodialysis |
|
|
Yakovenko A., Yesayan A., Lavrishcheva Y., Rumyantsev A.
|
| 卷 16, 编号 4 (2024) |
Multifactorial kidney damage in a comorbid patient |
|
|
Yumasheva V., Komarova I., Rachina S., Mayorov V., Melnik D., Mirzakhamidova S.
|
| 卷 16, 编号 4 (2024) |
Morphological structure of late kidney transplant dysfunction |
|
|
Rapetskaya N., Komissarov K., Dmitrieva M., Liatkoyskaya T., Kalachyk A.
|
| 卷 16, 编号 2 (2024) |
Morphological features of polycystic kidney in acute renal artery occlusion |
|
|
Trushkin R., Medvedev P., Lagoyskaya Y., Fettser D., Klementieva T.
|
| 卷 17, 编号 2 (2025) |
Prescription of off-label drugs to adult patients |
|
|
Lipatnikova V.
|
| 卷 16, 编号 1 (2024) |
Nephrogenic anemia in patients receiving renal replacement therapy, pathogenesis and resistance |
|
|
Ryasnyansky V., Shostka G., Anikonova L.
|
| 卷 15, 编号 3 (2023) |
Nephrological service of the Russian Federation 2022: post-covid period. Clinical nephrology |
|
|
Shilov E., Shilova M., Rumyantseva E., Batyushin M., Bevzenko A., Belskikh A., Veselkova N., Yesayan A., Ivliev S., Kotenko O., Petrova N., Statsenko M., Stolyar A.
|
| 卷 16, 编号 1 (2024) |
Nephrological service of the Russian Federation 2023: Part I. Renal Replacement Therapy |
|
|
Shilov E., Shilova M., Rumyantseva E., Batyushin M., Bevzenko A., Belskikh A., Veselkova N., Yesayan A., Ivliev S., Kotenko O., Petrova N., Statsenko M., Stolyar A.
|
| 卷 16, 编号 4 (2024) |
Nephrological service of the Russian Federation 2023: Part II. Resources and staff |
|
|
Shilov E., Shilova M., Rumyantseva E., Batyushin M., Bevzenko A., Belskikh A., Veselkova N., Yesayan A., Ivliev S., Kotenko O., Petrova N., Statsenko M., Stolyar A.
|
| 卷 17, 编号 1 (2025) |
Nephrology service of the Russian Federation 2024: Part I. Renal replacement therapy |
|
|
Shilov E., Shilova M., Rumyantseva E., Batyushin M., Bevzenko A., Belskikh A., Veselkova N., Yesayan A., Ivliev S., Kotenko O., Petrova N., Statsenko M., Stolyar A.
|
| 卷 17, 编号 3 (2025) |
New biomarkers of kidney diseases: a breakthrough in early and accurate diagnostics |
|
|
Aitbaev K., Murkamilov I., Fomin V., Murkamilova Z., Raimzhanov Z., Yusupov F., Yusupov A., Yusupova T., Yusupova Z., Baitelieva A.
|
| 卷 15, 编号 2 (2023) |
Experience with the use of eculizumab in the treatment of thrombotic microangiopathy in a patient with systemic lupus erythematosus |
|
|
Chuev N., Frolova N., Iskhakov R., Usatyuk S., Terentyeva N.
|
| 卷 15, 编号 2 (2023) |
Features of kidney damage in metabolic syndrome |
|
|
Vorotylov A., Mikhailova Z.
|
| 卷 17, 编号 2 (2025) |
Features of screening and diagnosis of renal cell carcinoma in kidney transplant recipients |
|
|
Trushkin R., Isaev T., Sokolov A., Sokolov S., Andreev S., Ho T.
|
| 卷 16, 编号 1 (2024) |
Features of the course and the prognosis in patients with multiple myeloma depending on the renal involvement |
|
|
Grigoryan Z., Marchenko Y., Khachatryan M.
|
| 卷 16, 编号 2 (2024) |
Features of the course of chronic kidney disease and left ventricle geometry in women and men at the pre-dialysis stage of the disease |
|
|
Murkamilov I., Aitbaev K., Fomin V., Yusupova T., Duysheeva G., Yusupov F.
|
| 卷 17, 编号 3 (2025) |
Acute kidney and liver damage in chronic alcohol intoxication |
|
|
Murkamilov I., Aitbaev K., Fomin V., Murkamilova Z., Raimzhanov Z., Solizhonov J., Yusupov A., Yusupov F., Yusupova T., Khabibullaev K.
|
| 卷 17, 编号 1 (2025) |
Acute kidney damage due to statin taken: case description and literature review |
|
|
Zubeev P., Kharlamova O., Motylev I., Zubeeva G., Suslova O., Shilov E.
|
| 卷 17, 编号 1 (2025) |
Acute kidney injury in patients with COVID-19: severity of inflammatory response and risk of chronic kidney disease development |
|
|
Mikhailova L., Perepelitsa S., Struchkov S., Orlova Y., Akchurina K.
|
| 卷 15, 编号 3 (2023) |
Acute tubulointerstitial nephritis of medicinal etiology: the focus is on antibacterial drugs |
|
|
Murkamilov I., Fomin V., Sabirov I., Yusupov F., Satkynalieva Z.
|
| 卷 16, 编号 3 (2024) |
Evaluation of the efficiency of nephroprotective therapy in patients with chronic kidney disease and arterial hypertension |
|
|
Zhmurov V., Ermakova P., Ermakova A., Zhmurov D., Vanuyto E.
|
| 卷 15, 编号 4 (2023) |
In memory of Lovchinsky Evgeny Valentinovich |
|
|
Editorial B.
|
| 卷 17, 编号 2 (2025) |
In memory of Natalia Arkadyevna Tomilina |
|
|
Editorial T.
|
| 卷 17, 编号 3 (2025) |
Pathogenesis of kidney injury in COVID-19 and diabetes mellitus: a review of current concepts |
|
|
Abdurakhimov A.
|
| 卷 16, 编号 1 (2024) |
The first case of successful pregnancy and natural childbirth in a patient on program hemodialysis in Uzbekistan |
|
|
Daminov B., Azizov S., Sharapov O., Safoeva S.
|
| 卷 16, 编号 4 (2024) |
Personalization of renal replacement therapy and its effect on survival of patients with stage 5 chronic kidney disease aged 60 and older |
|
|
Kurylovich K., Komissarov K., Krasko O., Kamisarau S., Ilyinchyk A., Prylutski S., Zhaholkin Y.
|
| 卷 16, 编号 4 (2024) |
Prospects for using the QRISK3 risk scale in patients with chronic kidney disease and sarcopenia |
|
|
Sokolova A., Stafeeva E., Stafeev A., Dragunov D., Arutyunov G.
|
| 卷 17, 编号 1 (2025) |
HIF-prolylhydroxylase inhibitors: the future for anemia treatment in patients with chronic kidney disease |
|
|
Levchenkova O., Novikov V., Vorobyova V., Kozlov S.
|
| 卷 16, 编号 3 (2024) |
Improving the health literacy of patients with ckd. Informed choice and collaborative decision making. further patient education when choosing a peritoneal dialysis method |
|
|
Berdinsky V., Kotenko O., Frolova N., Vinogradov V., Kargalskaya I., Ivanova E., Dorofeeva E.
|
| 卷 15, 编号 4 (2023) |
Post-contrast acute kidney injury: definition, prevalence and risk factors |
|
|
Sabirov I., Murkamilov I., Fomin V.
|
| 卷 15, 编号 4 (2023) |
Posttransfusion hemochromatosis and cardiorenal syndrome. Local register data |
|
|
Matveev M., Mikhailova Z.
|
| 卷 17, 编号 1 (2025) |
Right ventricle, pulmonary pressure and their relationship with renal function in patients with overweight and obesity |
|
|
Murkamilov I., Aitbaev K., Fomin V., Yusupov F., Yusupova T., Yusupova Z., Duysheeva G., Khakimov S., Abdurakhmanov I., Solizhonov Z., Ymankulov D., Khabibullaev K.
|
| 卷 17, 编号 1 (2025) |
Predictors of fatal outcome in patients hospitalized for graft pyelonephritis |
|
|
Andreev S., Trushkin R., Isaev T., Artyukhina L., Frolova N., Ilyukhina N., Narusova P., Abdullaev S., Dushkin A., Lysenko M., Zhuravleva M.
|
| 卷 15, 编号 3 (2023) |
The use of bilateral total transarterial kidney embolization for the combined treatment of patients with symptomatic autosodominant polycystic kidney disease and end-stage renal disease |
|
|
Vtorenko V., Trushkin R., Medvedev P., Vinogradov V., Isaev T., Sokolov S., Bondarenko S., Kolesnikov N., Ivanov K.
|
| 卷 15, 编号 1 (2023) |
Interleukin-6 receptor inhibitor levilimab in the treatment of COVID-19 in patients with chronic kidney disease |
|
|
Frolova N., Tomilina N., Usatyuk S., Dyakova E., Sysoeva I., Terentyeva N., Frolov M., Kim I.
|
| 卷 16, 编号 1 (2024) |
Application of kidney injury molecule-1 (KIM-1) for predicting urgent cardiovascular complications in acute cardiorenal syndrome |
|
|
Pivovarov D., Mikhailova Z.
|
| 卷 16, 编号 4 (2024) |
Application of the anolit in the prevention of peritoneal dialysis catheter-associated infections |
|
|
Berdinsky V., Kotenko O., Frolova N., Kargalskaya I., Ushakova A., Orlova A., Kozlov I., Suvorov O.
|
| 卷 17, 编号 3 (2025) |
Use of tocilizumab in treatment of chronic active antibody mediated kidney transplant rejection |
|
|
Rapetskaya N., Komissarov K., Dmitrieva M., Liatkoyskaya T., Kalachyk A.
|
| 卷 15, 编号 1 (2023) |
Pro-inflammatory cytokines and their participation in the development of cardiovascular calcification in patients with chronic kidney disease |
|
|
Mambetova A., Khutueva M., Tkhabisimova I.
|
| 卷 17, 编号 2 (2025) |
Prediction of urolithiasis development in patients on statin therapy taking into account genetic polymorphisms |
|
|
Kovalenko A., Nikitina V.
|
| 卷 16, 编号 1 (2024) |
Prognostic value of the Charlson comorbidity index in patients aged 60 years and older starting chronic dialysis treatment |
|
|
Kurylovich K., Komissarov K., Krasko O.
|
| 卷 17, 编号 2 (2025) |
Intermediate results of a prospective multicenter observational study of long-term therapy with eculizumab biosimilar in patients with atypical hemolytic uremic syndrome (ECU-аHUS-N03) |
|
|
Kotenko O., Vinogradov V., Ivanova E., Shutov E., Dudko M., Mayorov V., Kudlay D., Markova O., Kolobov E., Borozinets A.
|
| 卷 15, 编号 3 (2023) |
Development of ideas about urolithiasis |
|
|
Subotyalov M.
|
| 卷 15, 编号 1 (2023) |
Early predictors of kidney damage in children and adolescents with type 1 diabetes mellitus |
|
|
Zeinebekova A., Umarova A., Usmanova D., Turkara A., Kovalchuk V., Dyussenova S.
|
| 卷 16, 编号 3 (2024) |
Prevalence and diagnosis of autosomal dominant polycystic kidney disease |
|
|
Dzhalilzoda S.
|
| 卷 17, 编号 1 (2025) |
Prevalence and pathogenesis of kidney damage in non-alcoholic fatty liver disease – possibilities of early diagnostics using fluorescence organoscopy |
|
|
Lelyavina T., Galagudza M., Sonin D., Popov S., Guseinov R., Beshtoev A., Malyshev E.
|
| 卷 15, 编号 3 (2023) |
Prevalence of sarcopenia in patients with chronic heart failure and chronic kidney disease |
|
|
Sokolova A., Dragunov D., Arutyunov G.
|
| 卷 17, 编号 2 (2025) |
Rheumatoid arthritis? Systemic lupus erythematosus? – Fabry disease |
|
|
Grigoryeva E., Stolyarevich E., Starikov D., Magdeeva N., Kondrashova I., Zhokhova T., Pasechnaya N.
|
| 卷 15, 编号 2 (2023) |
Regional citrate anticoagulation with 4% sodium citrate |
|
|
Avetisyan E., Kostritsa N.
|
| 卷 15, 编号 2 (2023) |
Rare benign kidney tumors. Review of clinical cases |
|
|
Trushkin R., Isaev T., Medvedev P., Sokolov S., Parshin V., Manchenko O., Varyasin V., Berezhnaya E., Klementyeva T.
|
| 卷 15, 编号 3 (2023) |
The burden of COVID-19 in a heterogeneous population of immunocompromised patients – realities of the postpandemic. Terapevticheskii Arkhiv (Ter. Arkh.) |
|
|
Avdeev S., Chulanov V., Alekseeva E., Alyoshina O., Bereznikov A., Kotenko O., Lila A., Mutovina Z., Parovichnikova E., Fomina D., Frolova N., Shevchenko A.
|
| 卷 16, 编号 2 (2024) |
The results of a multifactorial analysis to identify medical and social factors associated with the quality of life of patients with chronic kidney disease on hemodialysis |
|
|
Kotenko O., Abolyan L., Kuteinikov V., Arsanukaev I., Dorofeeeva E., Vinogradov V.
|
| 卷 16, 编号 3 (2024) |
ISPD guidelines on catheter-associated infections 2023 |
|
|
Chow K., Li P., Cho Y., Abu-Alfa A., Bavanandan S., Brown E., Cullis B., Edwards D., Ethier I., Hurst H., Ito Y., Proenc´a de Moraes T., Morelle J., Runnegar N., Saxena A., So S., Tian N., Johnson D.
|
| 卷 16, 编号 2 (2024) |
Roxadustat: treatment of anemia and additional clinical effects (literature review) |
|
|
Mikhailova N.
|
| 卷 17, 编号 3 (2025) |
Relationship between nutritional insufficiency and progression of acute kidney injury in children with signs of multiple organ failure |
|
|
Ashurova G., Mamatkulov I.
|
| 卷 17, 编号 2 (2025) |
Zinner syndrome in a child |
|
|
Morozov S., Kiseleva N., Chizhov A., Grigoryan L., Poleshchuk L., Podgorny A.
|
| 1 - 100 的 129 信息 |
1 2 > >> |
